Compare LITS & SEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITS | SEV |
|---|---|---|
| Founded | 2000 | 2019 |
| Country | United States | United States |
| Employees | 4 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.2M | 48.4M |
| IPO Year | N/A | N/A |
| Metric | LITS | SEV |
|---|---|---|
| Price | $1.15 | $2.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 287.2K | ★ 654.6K |
| Earning Date | 05-12-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $17,757.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.95 | $1.29 |
| 52 Week High | $3.03 | $11.24 |
| Indicator | LITS | SEV |
|---|---|---|
| Relative Strength Index (RSI) | 47.11 | 50.02 |
| Support Level | $0.98 | $2.25 |
| Resistance Level | $1.16 | $3.26 |
| Average True Range (ATR) | 0.07 | 0.32 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 39.13 | 41.58 |
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Aptera Motors Corp develops and produces energy-efficient solar-powered, battery-electric vehicles designed to maximize solar energy utilization. The company focuses on lightweight composite structures and solar technology to minimize environmental impact and reduce reliance on charging infrastructure.